HOME >> MEDICINE >> NEWS
Should the standard guidelines for assessing prostate cancer control be changed?

The specificity and sensitivity of the ASTRO definition to predict clinical failure was 60 percent and 72 percent, respectively. Again, using three alternate definitions of clinical failure, the researchers demonstrated specificity and sensitivity results of 67 and 78 percent, 66 and 77 percent, and 64 and 74 percent.

"These alternate definitions potentially offer more accuracy in predicting who will remain free of cancer after treatment and who will truly develop metastatic disease based on a patient's post-treatment PSA levels," Horwitz said. "What's more, these results add to the current discussion in the radiation oncology community and to the body of evidence suggesting modifications to the standard ASTRO definition to predict treatment failure."

Other authors of the study include Howard D. Thames, Ph.D., department of biomathematics, University of Texas M. D. Anderson Cancer Center, Houston; Deborah A. Kuban M.D., division of radiation oncology, University of Texas M. D. Anderson Cancer Center; Larry B. Levy, M.S., department of biomathematics, University of Texas M. D. Anderson Cancer Center; Patrick A. Kupelian, M.D., department of radiation oncology, The Cleveland Clinic Foundation, Cleveland, Ohio; Alvaro A. Martinez, M.D., William Beaumont Hospital, Royal Oak, Mich.; Jeffrey M. Michalski, M.D., department of radiation oncology, Mallinckrodt Institute of Radiology, St. Louis, Mo.; Thomas M. Pisansky M.D., division of radiation oncology, Mayo Clinic, Rochester Minn.; Howard M. Sandler, M.D., department of radiation oncology, University of Michigan, Ann Arbor; William U. Shipley, M.D., department of radiation oncology, Massachusetts General Hospital, Boston; Michael J. Zelefsky, M.D., department of radiation oncology, Memorial Sloan-Kettering Cancer Center, New York City; Gerald E. Hanks, M.D., retired from the department of radiation oncology, Fox Chase Cancer Center, Philadelphia, Pa.; and Anthony L. Zietman, M.D., department of radiation
'"/>

Contact: Karen Carter Mallet
k_carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
20-Oct-2003


Page: 1 2 3

Related medicine news :

1. Should medical students have earlier contact with patients?
2. Should nurses conduct breast cancer follow-up visits?
3. Should compulsory screening of immigrants be part of UK public health policy?
4. Should living liver donation be available in the NHS?
5. Should ambulance crews perform emergency breathing procedure?
6. C-reactive proteins: Should everyone be tested?
7. Should people with dementia be electronically tagged?
8. Should we help to create disabled babies?
9. Should people with diabetes sleep with the lights on?
10. Should women be screened for domestic violence?
11. Should banks be liable for pollution caused by companies that borrow from them?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to ... Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed a ... or restricted lighting. As such, it eliminates the need to turn on a light ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that ... New Product Innovation Award for Its fibromyalgia pain management ... medical device market research by Frost & Sullivan,s industry experts. ... pain relief product, the AVACEN 100, offers a safe and ... pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update ... Puerto Rico , where the company manufactures ... Following a comprehensive onsite assessment, the ... temporary loss of power and minimal water damage due ... have resumed, and the company expects to return to ...
Breaking Medicine Technology:
Cached News: